Inventor · disambiguated record
Matthew Lebar
Also filed as: LEBAR MATTHEW
9 granted patents·1 pending application·17 citations·filing 1990–2019
81Inventor score
Top patents by PatentIndex Score
10 records- 0170US8940945B2Materials and methods for reduction of protein tau and treatment of neurodegenerative diseasesDICKEY CHAD·Filed 2011·Granted Jan 27, 2015·1 cites·3 claims
- 0269US2019218165A1Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative DiseasesUNIV SOUTH FLORIDA·Filed 2019·Application pending·0 cites
- 0366US10864266B2Modified lipopolysaccharide glycoform and method of useUNIV PRINCETON·Filed 2019·Granted Dec 15, 2020·0 cites·2 claims
- 0464US9206103B2Materials and methods for reduction of protein tau and treatment of neurodegenerative diseasesUNIV SOUTH FLORIDA·Filed 2014·Granted Dec 8, 2015·0 cites·14 claims
- 0562US10525126B2Modified lipopolysaccharide glycoform and method of useUNIV PRINCETON·Filed 2017·Granted Jan 7, 2020·0 cites·12 claims
- 0662US10358405B2Myricanol derivatives and uses thereof for treatment of neurodegenerative diseasesUNIV SOUTH FLORIDA·Filed 2018·Granted Jul 23, 2019·0 cites·8 claims
- 0759US9598338B2Myricanol derivatives and uses thereof for treatment of neurodegenerative diseasesDICKEY CHAD·Filed 2013·Granted Mar 21, 2017·0 cites·9 claims
- 0858US10287227B2Myricanol derivatives and uses thereof for treatment of neurodegenerative diseasesUNIV SOUTH FLORIDA·Filed 2017·Granted May 14, 2019·0 cites·17 claims
- 0951US9677052B2Modified lipopolysaccharide glycoform and method of useSILHAVY THOMAS J·Filed 2015·Granted Jun 13, 2017·0 cites·5 claims
- 1032US5106048ASupport standsLEBAR MATTHEW·Filed 1990·Granted Apr 21, 1992·16 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →